Previous 10 | Next 10 |
Viatris Announces Appointment of Leo Groothuis to Company's Board of Directors PR Newswire PITTSBURGH , May 22, 2023 /PRNewswire/ -- Viatris Inc. (NASDAQ: VTRS), a global healthcare company, today announced that as part of its ongoing board refreshment effort...
Securities Litigation Partner James (Josh) Wilson Encourages Investors Who Suffered Losses Exceeding $100,000 In Viatris To Contact Him Directly To Discuss Their Options New York, New York--(Newsfile Corp. - May 21, 2023) - Faruqi & Faruqi, LLP, a leading national securities law firm, is inv...
Securities Litigation Partner James (Josh) Wilson Encourages Investors Who Suffered Losses Exceeding $100,000 In Viatris To Contact Him Directly To Discuss Their Options New York, New York--(Newsfile Corp. - May 19, 2023) - Faruqi & Faruqi, LLP, a leading national securities law firm, is inv...
2023-05-18 06:28:00 ET Companies that produce generic drugs aren't known for being exciting investments, and there's little chance they'll ever expand as fast as your average tech stock or most other growth stocks. If they can manage to be a safer holding than faster-growing stocks, though,...
Securities Litigation Partner James (Josh) Wilson Encourages Investors Who Suffered Losses Exceeding $100,000 In Viatris To Contact Him Directly To Discuss Their Options New York, New York--(Newsfile Corp. - May 17, 2023) - Faruqi & Faruqi, LLP, a leading national securities law firm, is inv...
Viatris to Participate in Goldman Sachs 44th Annual Global Healthcare Conference PR Newswire PITTSBURGH , May 17, 2023 /PRNewswire/ -- Viatris Inc. ( NASDAQ : VTRS ), a global healthcare company, today announced the company will participate in the ...
Viatris Publishes Sustainability Report Showcasing 2022 Progress on Building Sustainable Access to Medicine PR Newswire Supplied medicines to approximately 1 billion patients globally PITTSBURGH , May 16, 2023 /PRNewswire/ -- Viatris Inc. (NASDAQ: VTR...
2023-05-09 20:42:32 ET Summary Davis Selected Advisers 13F portfolio value increased from $14.71B to $15.13B this quarter. They increased Amazon and JD.com while reducing Quest Diagnostics. The top three positions are Meta Platforms, Berkshire Hathaway, and Wells Fargo, and th...
2023-05-08 12:37:03 ET Viatris Inc. (VTRS) Q1 2023 Results Conference Call May 08, 2023 08:30 AM ET Company Participants Bill Szablewski - Head of Capital Markets Scott Smith - Incoming Chief Executive Officer Rajiv Malik - President Sanjeev Narula - Chief Fi...
2023-05-08 10:57:48 ET Summary Viatris has struggled to gain ground over the last year. This has happened despite management stressing the free cash flow generation ability of the business. Q1-2023 results showed just how much work management needs to do to make this a comebac...
News, Short Squeeze, Breakout and More Instantly...
2024-07-26 12:25:00 ET The late comedian Rodney Dangerfield was famous for his catchphrase, "I don't get no respect." Does Dangerfield's line apply to some stocks today? Absolutely. Three Motley Fool contributors think they've found surprisingly underrated pharmaceutical stocks to b...
NORTHAMPTON, MA / ACCESSWIRE / July 23, 2024 / No country can make every medicine people need, and no medicine is made in every country. If a country or region relies on supply only from within their region and they experience a crisis, there is a risk people won't get the medicines they need, w...
NORTHAMPTON, MA / ACCESSWIRE / July 18, 2024 / Viatris is a global healthcare company focused on bringing high-quality medicines to patients through a hybrid approach that bridges the traditional divide between generics and brands, combining the best of both, to more holistically address healthc...